IP Library Granted Patent US 7,439,040
Granted Patent B2
US 7,439,040 · App. 11/193,615 · Granted Oct 21, 2008

Protease regulator screening assay

Assignee: Novartis Vaccines and Diagnostics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,439,040
App. No.
11/193,615
Granted
Oct 21, 2008
Kind
B2
Abstract

A polypeptide containing an anchor region, a protease recognition site, and a detectable signal region can be produced recombinantly and directly attached to a solid support. The polypeptide is useful for screening protease regulators, especially protease inhibitors.

Claims (7)

1. A method of forming a substrate for use in a screening assay for protease regulators comprising binding a polypeptide consisting of a polyamino acid sequence to a solid support comprising a protein via a protein-protein interaction having a K d of no more than 10 −8 , wherein the polypeptide comprises:

an anchor region,

a protease recognition site which comprises

a) a cleavable peptide bond, and

b) at least 3 naturally adjacent amino acids on each side of the cleavable peptide bond; and

a detectable signal region, wherein the polypeptide binds to the protein via the anchor region.

2. The method of claim 1 wherein the protein is an antibody.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2017
From: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
To: GRIFOLS WORLDWIDE OPERATIONS LIMITED
Reel/Frame 043880/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2017
From: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
To: GRIFOLS WORLDWIDE OPERATIONS LIMITED
Reel/Frame 043873/0561 →
RELEASE OF SECURITY INTEREST Recorded Feb 6, 2017
From: DEUTSCHE BANK AG NEW YORK BRANK
To: GRIFOLS THERAPEUTICS INC.; GRIFOLS SHARED SERVICES NORTH AMERICA INC.; GRIFOLS DIAGNOSTIC SOLUTIONS INC.
Reel/Frame 041638/0527 →
SECURITY AGREEMENT Recorded Feb 27, 2014
From: GRIFOLS INC.; GRIFOLS THERAPEUTICS INC.; GRIFOLS-CHIRON DIAGNOSTICS CORP.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032367/0001 →
CHANGE OF NAME Recorded Dec 19, 2007
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 020288/0242 →
Continuity (4)
Division 1022539000 · Aug 20, 2002
Continuation 0899705500 · Oct 17, 1997
Provisional Application 6002881700 · Oct 17, 1996
Related Publication 20060292659A1 · Dec 28, 2006